Search Results

Therapeutics Update

Cannabis and Glaucoma

The importance of strain and chemical composition.

Ahmad A. Aref, MD, MBA

The Adherence Problem

Its scope and strategies for its reduction.

Henry D. Jampel, MD, MHS

Practice Pointers

Compassionate Communication

Strategies for building relationships with newly diagnosed patients and those with progressing glaucoma.

Henry D. Jampel, MD, MHS; Richard J. Madonna, OD; Steven L. Mansberger, MD, MPH; Igor Estrovich, MD; Leo Semes, OD; Julia Song, MD; and Joseph Sowka, OD

Practice Pointers

Compassionate Communication

Strategies for building relationships with newly diagnosed patients and those with progressing glaucoma.

Henry D. Jampel, MD, MHS; Richard J. Madonna, OD; Steven L. Mansberger, MD, MPH; Igor Estrovich, MD; Leo Semes, OD; Julia Song, MD; and Joseph Sowka, OD

Adjunctive Medical Therapy for Glaucoma

Optimizing patients' outcomes.

Henry D. Jampel, MD, MHS

Therapeutics Update

Are Your Patients Instilling Their Drops?

Glaucoma Today asked several members of the glaucoma community the following question: How do you know whether patients are using their topical glaucoma medications?

Henry D. Jempel, MD, MHS; Kelly W. Muir, MD; Gary D. Novack, PHD; and Alan L. Robin, MD

5 Questions With Henry Jampel, MD, MHS

Dr. Jampel describes his long-term research goals, his approach to the management of concurrent cataract and glaucoma, and the influences on his life, professional and private.

5 Questions With Anne L. Coleman, MD, PhD

Dr. Coleman contemplates the influence of her fellowship training and the challenges inherent to large, government-funded studies.

Anne L. Coleman, MD, PhD